Anti-tumor effect of berberine on chronic lymphocytic leukemia cells-Reference-Cited by-同舟云学术

Anti-tumor effect of berberine on chronic lymphocytic leukemia cells

Published:2022-09-29 Issue:12 Volume:39 Page:
ISSN:1559-131X
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Abdollahi Maryam,Mohammadlou Maryam,Hemati Maral,Baharlou Rasoul,Manouchehri Doulabi Ehsan,Ghahremanfard Farahnaz^ORCID,Sarabi Mohammad Amir,Kokhaei Parviz^ORCID

Funder

Semnan University of Medical Sciences and Health Services

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12032-022-01818-5.pdf

Reference35 articles.

1. Burger JA, O’Brien S. Evolution of CLL treatment—from chemoimmunotherapy to targeted and individualized therapy. Nat Rev Clin Oncol. 2018;15(8):510–27.

2. Sun X, et al. Ki-67 contributes to normal cell cycle progression and inactive X heterochromatin in p21 checkpoint-proficient human cells. Mol Cell Biol. 2017;37(17):e00569-e616.

3. AL-Mudallal SS, Jasim HN. Evaluation of Bcl 2 and Ki 67 expression in Chronic Lymphocytic Leukemia. J Faculty Med Baghdad. 2012;54(4):335–9.

4. Tan M-F, et al. Expression of ki-67 in chronic lymphocytic leukemia and its clinical significance. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015;23(2):318–21.

5. Burger JA, Chiorazzi N. B cell receptor signaling in chronic lymphocytic leukemia. Trends Immunol. 2013;34(12):592–601.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of inflammation by berberine: Molecular mechanism and network pharmacology analysis;Phytomedicine;2024-06